The overall objective of the Sphingolipid Animal Cancer Pathobiology (SACP) Shared Resource Core is to provide the Project Leaders with the ability to utilize animal models of carcinogenesis in the execution of their research projects and to maintain genetically engineered mice for the carcinogenesis models. The SACP Shared Resource Core will serve as an essential resource for the use of all animal manipulations needed by the Projects. By centralizing all aspects of in vivo research, the SACP Core will facilitate more rapid and reliable data and minimize the cost of utilizing animal models. The overall aims of the proposal are:
Specific Aim 1 : Ensure proper planning of in vivo research models, provide necessary facilities and expertise for carcinogenesis models and facilitate use of critical Shared Resources. We will a) assist investigators with choosing and/or designing the most appropriate animal model to test hypotheses, including lipid-based transgenic and gene-altered mice: b) provide essential facilities as well as faculty and staff expertise to support research projects in animal models of carcinogenesis;and c) facilitate access to and use of existing shared resources at SBU, including small animal imaging, drug metabolism and pharmacokinetics, tissue biorepository and transgenic and gene knockout generation facilities.
Specific Aim 2 : Enhance and maximize the utility of animal models and provide complementary and alternative approaches. For this Aim we will a) maintain stocks of breeding animals for the Project investigators;b) assist with utilization of carcinogenesis models;and c) provide Project investigators with alternatives to animal research via generation of cell lines from lipid-based genetically engineered mice.
Specific Aim 3 : Provide investigators with assistance and expertise in data collection, interpretation, analysis and management.
In Aim 3 we will a) provide investigators with expertise in pathology, animal model pathobiology and immunohistochemistry;b) assist with data analysis, interpretation and project progression;and c) facilitate sample storage for future studies in animal models of carcinogenesis. Key personel for the SACP Core include an experienced pathologist and a scientific director for Biobanking. Together, these services will provide the necessary expertise in rodent patholgoy and pathobiology associated with carcinogenesis models in additon to biobanking samples generated from animal models of carcinogenesis. These efforts will facilitate the research in this proposal and will provide the expertise to support the Project Leaders. This core is already evolving as a unique and enabling core that is critical for the success of the Program Project.

Public Health Relevance

The SACP Shared Resource Core will serve as a hub of knowledge and resources for the implementation of pre-clinical research in sphingolipids and cancer. This essential resource will facilitate the discovery and determination of novel targets in carcinogenesis, as well as further the development of novel potential therapeutics. The SACP Core will serve as a crucial first step in determining potential mechanisms, interventions and novel therapeutic targets carcinogenesis.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1-RPRB-J (M1))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
State University New York Stony Brook
Stony Brook
United States
Zip Code
Adada, Mohamad; Canals, Daniel; Hannun, Yusuf A et al. (2014) Sphingolipid regulation of ezrin, radixin, and moesin proteins family: implications for cell dynamics. Biochim Biophys Acta 1841:727-37
Jones, E Ellen; Dworski, Shaalee; Canals, Daniel et al. (2014) On-tissue localization of ceramides and other sphingolipids by MALDI mass spectrometry imaging. Anal Chem 86:8303-11
Jiang, Wenhui; Ogretmen, Besim (2014) Autophagy paradox and ceramide. Biochim Biophys Acta 1841:783-92
Truman, Jean-Philip; García-Barros, Mónica; Obeid, Lina M et al. (2014) Evolving concepts in cancer therapy through targeting sphingolipid metabolism. Biochim Biophys Acta 1841:1174-88
Garcia-Barros, Monica; Coant, Nicolas; Truman, Jean-Philip et al. (2014) Sphingolipids in colon cancer. Biochim Biophys Acta 1841:773-82
Boppana, Nithin B; Kodiha, Mohamed; Stochaj, Ursula et al. (2014) Ceramide synthase inhibitor fumonisin B1 inhibits apoptotic cell death in SCC17B human head and neck squamous carcinoma cells after Pc4 photosensitization. Photochem Photobiol Sci 13:1621-7
Perry, David M; Newcomb, Benjamin; Adada, Mohamad et al. (2014) Defining a role for acid sphingomyelinase in the p38/interleukin-6 pathway. J Biol Chem 289:22401-12
Korbelik, Mladen; Banáth, Judit; Sun, Jinghai et al. (2014) Ceramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposure. Int Immunopharmacol 20:359-65
Korbelik, Mladen; Zhang, Wei; Saw, Kyi Min et al. (2013) Cationic ceramides and analogues, LCL30 and LCL85, as adjuvants to photodynamic therapy of tumors. J Photochem Photobiol B 126:72-7
Cheng, Joseph C; Bai, Aiping; Beckham, Thomas H et al. (2013) Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. J Clin Invest 123:4344-58

Showing the most recent 10 out of 119 publications